检索历史清除

首页> Haematologica> A phase I study of idarubicin dose escalation with amisfostine and high-dose cytarabine in patients with relapsed acute myelogenous leukemia and myelodysplastic syndromes.

A phase I study of idarubicin dose escalation with amisfostine and high-dose cytarabine in patients with relapsed acute myelogenous leukemia and myelodysplastic syndromes.

导出原文传递

翻译打印收藏纠错

作者： Garcia Manero G ^[1] ; Faderl S ; Giles F ; Thomas D ; Cortes J ; O'Brien S ; Davis J ; Kantarjian HM ; Estey E

作者单位： Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Box 428, 1515 Holcombe Boulevard, Houston, TX 77030, USA. ggarciam@mdanderson.org ^[1]

关键词 Leukemia Myeloid 白血病髓样

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交